Protection against kainate neurotoxicity by pyrrolidine dithiocarbamate

Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):320-6. doi: 10.1111/j.1440-1681.2004.03990.x.

Abstract

The effect of pyrrolidine dithiocarbamate (PDTC) on kainate (KA)-induced neurotoxicity was examined in Sprague-Dawley rats. At 10 mg/kg, i.p., KA produced seizures accompanied by neuronal loss in the hippocampus and increased levels of malondialdehyde (MDA) and protein carbonyl. Pretreatment with PDTC (100 or 200 mg/kg, p.o., every 12 h x 5) blocked KA-induced neurotoxicities (seizures, increases in MDA and protein carbonyl and neuronal losses) in a dose-dependent manner. These effects were counteracted by the adenosine A(1) receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (25 or 50 micro g/kg, i.p.), but not by the A(2A) receptor antagonist 1,3,7-trimethyl-8-(3-chlorostyryl)xanthine (0.5 or 1 mg/kg, i.p.) or the A(2B) receptor antagonist alloxazine (1.5 or 3.0 mg/kg, i.p.). Our results suggest that the anticonvulsant and neuroprotective effects of PDTC are mediated, at least in part, via adenosine A(1) receptor stimulation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Antagonists / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / pathology
  • Kainic Acid / toxicity*
  • Male
  • Neuroprotective Agents / pharmacology*
  • Pyrrolidines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Seizures / pathology
  • Seizures / prevention & control
  • Thiocarbamates / pharmacology*

Substances

  • Excitatory Amino Acid Antagonists
  • Neuroprotective Agents
  • Pyrrolidines
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid
  • Kainic Acid